<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="513">
  <stage>Registered</stage>
  <submitdate>12/09/2005</submitdate>
  <approvaldate>23/09/2005</approvaldate>
  <actrnumber>ACTRN12605000474651</actrnumber>
  <trial_identification>
    <studytitle>Effect of breathing circuit size on paediatric ventilatory parameters</studytitle>
    <scientifictitle>Effect of Adult and infant breathing circuits on intubated paediatric ventilator patients with respect to delivered tidal volume.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Paediatric patient receiving ventilatory support</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Study (Adult or infant breathing circuit, depending on weight) for 12 hours. Participants will then be crossed over to the opposing circuit.</interventions>
    <comparator>Control (standard paediatric breathing circuit).</comparator>
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Delivered Tidal Volume</outcome>
      <timepoint>Measured every 30 minutes</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Arterial Blood Gas</outcome>
      <timepoint>Taken every 3 hours.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Oxygenation index</outcome>
      <timepoint>Taken every 3 hours.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients weighing between 10-35kg.Patients that are intubated.Patients that have been ventilated for over 24hrs.Patients that have any kind of physical lung injury, that could significantly alter lung characteristics i.e. Pneumothorax.Patients that have not been able to be stabile in order for cross over to occur.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Opaque sealed envelopes</concealment>
    <sequence>Generated by independent party, randomised to blocks</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/02/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Fisher &amp; Paykel Healthcare</primarysponsorname>
    <primarysponsoraddress>15 Maurice Paykel Place. East Tamaki. Auckland 2013</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Fisher &amp; Paykel Healthcare</fundingname>
      <fundingaddress>15 Maurice Paykel Place. East Tamaki. Auckland</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>N/A</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Mater Misericordiae Health services Brisbane</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Geraldine Keogh</name>
      <address>Fisher &amp; Paykel Healthcare
PO Box 14 348
Panmure</address>
      <phone>+ 64 9 574 0100</phone>
      <fax>+ 64 9 574 0158</fax>
      <email>geraldine.keogh@fphcare.co.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr. Andreas Schibler</name>
      <address>Mater Children's Hospital Mater
Mater Misericordiae Hospitals
South Brisbane QLD 4101</address>
      <phone>+61 7 38408111</phone>
      <fax>+61 7 38401642</fax>
      <email>andreas_schibler@mater.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>